Literature DB >> 17431450

Combined cardiac and liver transplantation for the treatment of familial amyloidosis.

Brian G Schwartz1, Johannes J Kuiper, Göran B Klintmalm, Marvin J Stone, Jeffrey M Schussler.   

Abstract

Entities:  

Year:  2007        PMID： 17431450      PMCID： PMC1849877          DOI： 10.1080/08998280.2007.11928274

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  17 in total

1.  Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.

Authors:  A García-Herola; M Prieto; S Pascual; M Berenguer; B López-Viedma; J Mir; J J Vilchez; J Berenguer
Journal:  Liver Transpl Surg       Date:  1999-05

Review 2.  Molecular mechanisms of amyloidosis.

Authors:  Giampaolo Merlini; Vittorio Bellotti
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

Review 3.  Amyloidosis: a final common pathway for protein deposition in tissues.

Authors:  M J Stone
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

4.  Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I.

Authors:  P Parrilla; P Ramirez; L F Andreu; S F Bueno; R Robles; M Miras; F Acosta; D Viader-Farre; P de Mingo; J Bermejo; S F Garrido; M Munar-Ques
Journal:  Transplantation       Date:  1997-08-27       Impact factor: 4.939

5.  Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy.

Authors:  Nobuhiro Kotani; Takeshi Hattori; Shingo Yamagata; Takahiko Tokuda; Akira Shirasawa; Shuhei Yamaguchi; Shotai Kobayashi; Shu-ichi Ikeda
Journal:  Amyloid       Date:  2002-03       Impact factor: 7.141

6.  Liver transplantation as a treatment for familial amyloidotic polyneuropathy.

Authors:  M Skinner; W D Lewis; L A Jones; J Kasirsky; K Kane; S T Ju; R Jenkins; R H Falk; R W Simms; A S Cohen
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391

7.  Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.

Authors:  M Yazaki; T Tokuda; A Nakamura; T Higashikata; J Koyama; K Higuchi; Y Harihara; S Baba; F Kametani; S Ikeda
Journal:  Biochem Biophys Res Commun       Date:  2000-08-11       Impact factor: 3.575

8.  Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis.

Authors:  A J Stangou; P N Hawkins; N D Heaton; M Rela; M Monaghan; P Nihoyannopoulos; J O'Grady; M B Pepys; R Williams
Journal:  Transplantation       Date:  1998-07-27       Impact factor: 4.939

9.  Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation.

Authors:  P R Bergethon; T D Sabin; D Lewis; R W Simms; A S Cohen; M Skinner
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

10.  Orthotopic liver transplantation for familial amyloidotic polyneuropathy.

Authors:  W D Lewis; M Skinner; R W Simms; L A Jones; A S Cohen; R L Jenkins
Journal:  Clin Transplant       Date:  1994-04       Impact factor: 2.863
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.